APIM Therapeutics AS is a biotechnology company that develops first-in-class peptide therapeutics targeting PCNA to disrupt cellular stress responses and overcome cancer treatment resistance
APIM Therapeutics AS is a biotechnology company that develops first-in-class peptide therapeutics targeting PCNA to disrupt cellular stress responses and overcome cancer treatment resistance.